Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4994
rs4994
0.030 GeneticVariation BEFREE A tryptophan to arginine (Trp64Arg) mutation in the beta 3-adrenergic receptor (beta 3-AR) gene has been implicated in diabetes and obesity. 8826971

1996

dbSNP: rs1444739794
rs1444739794
GCK
0.010 GeneticVariation BEFREE The V62A mutation, which has not been previously reported, cosegregated with diabetes in the N2 family. 9736233

1998

dbSNP: rs1267969615
rs1267969615
ACE
0.070 GeneticVariation BEFREE Relative nocturnal systolic and diastolic pressures in patients with diabetes were higher than in healthy age- and height-matched controls; no association was found with the angiotensinogen gene M235T polymorphism. 9950302

1999

dbSNP: rs699
rs699
AGT
0.070 GeneticVariation BEFREE Relative nocturnal systolic and diastolic pressures in patients with diabetes were higher than in healthy age- and height-matched controls; no association was found with the angiotensinogen gene M235T polymorphism. 9950302

1999

dbSNP: rs1267969615
rs1267969615
ACE
0.070 GeneticVariation BEFREE We examined angiotensin-converting enzyme (ACE) DD/II and angiotensinogen (Atg) M235T polymorphism in a cohort of Chinese patients with type II diabetes with an average duration of diabetes of 14 years. 10352194

1999

dbSNP: rs699
rs699
AGT
0.070 GeneticVariation BEFREE We examined angiotensin-converting enzyme (ACE) DD/II and angiotensinogen (Atg) M235T polymorphism in a cohort of Chinese patients with type II diabetes with an average duration of diabetes of 14 years. 10352194

1999

dbSNP: rs28936379
rs28936379
0.010 GeneticVariation BEFREE Localisation of presenilin 2 in human and rodent pancreatic islet beta-cells; Met239Val presenilin 2 variant is not associated with diabetes in man. 10362543

1999

dbSNP: rs1800566
rs1800566
0.020 GeneticVariation BEFREE No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes in the Danish population. DIEGG and DSGD. Danish IDDM Epidemiology and Genetics Group and The Danish Study Group of Diabetes in Childhood. 10447260

1999

dbSNP: rs1258159645
rs1258159645
0.010 GeneticVariation BEFREE No linkage of P187S polymorphism in NAD(P)H: quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes in the Danish population. DIEGG and DSGD. Danish IDDM Epidemiology and Genetics Group and The Danish Study Group of Diabetes in Childhood. 10447260

1999

dbSNP: rs1801278
rs1801278
0.050 GeneticVariation BEFREE The allele frequencies of the Gly972Arg variant of the insulin receptor substrate-1 (IRS-1) gene and the Ala54Thr variant of the fatty acid binding protein 2 (FABP2) gene were compared in 992 normal control subjects and three patient groups: 1) 321 type 2 diabetic individuals, 2) 260 severely obese individuals, and 3) 258 markedly hyperinsulinemic individuals without diabetes. 10480621

1999

dbSNP: rs1799883
rs1799883
0.030 GeneticVariation BEFREE The allele frequencies of the Gly972Arg variant of the insulin receptor substrate-1 (IRS-1) gene and the Ala54Thr variant of the fatty acid binding protein 2 (FABP2) gene were compared in 992 normal control subjects and three patient groups: 1) 321 type 2 diabetic individuals, 2) 260 severely obese individuals, and 3) 258 markedly hyperinsulinemic individuals without diabetes. 10480621

1999

dbSNP: rs137852783
rs137852783
0.040 GeneticVariation BEFREE The lower penetrance D76N and Q59L mutations were more prevalent and were associated with a relative risk of 12.6 for diabetes and with decreased glucose-stimulated insulin-secretion in nondiabetic subjects. 10545531

1999

dbSNP: rs137852784
rs137852784
0.020 GeneticVariation BEFREE The lower penetrance D76N and Q59L mutations were more prevalent and were associated with a relative risk of 12.6 for diabetes and with decreased glucose-stimulated insulin-secretion in nondiabetic subjects. 10545531

1999

dbSNP: rs1169305
rs1169305
0.020 GeneticVariation BEFREE A 5-nucleotide insertion in intron 1 was present in both diabetic members of a small family, but Gly52Ala, Gly574Ser, and the intron 10 mutation did not segregate with diabetes. 10690959

2000

dbSNP: rs1406167595
rs1406167595
0.010 GeneticVariation BEFREE A 5-nucleotide insertion in intron 1 was present in both diabetic members of a small family, but Gly52Ala, Gly574Ser, and the intron 10 mutation did not segregate with diabetes. 10690959

2000

dbSNP: rs142318174
rs142318174
0.010 GeneticVariation BEFREE A 5-nucleotide insertion in intron 1 was present in both diabetic members of a small family, but Gly52Ala, Gly574Ser, and the intron 10 mutation did not segregate with diabetes. 10690959

2000

dbSNP: rs587778393
rs587778393
0.010 GeneticVariation BEFREE A 5-nucleotide insertion in intron 1 was present in both diabetic members of a small family, but Gly52Ala, Gly574Ser, and the intron 10 mutation did not segregate with diabetes. 10690959

2000

dbSNP: rs1800562
rs1800562
0.100 GeneticVariation BEFREE One of the 220 patients (0.45%) with diabetes was homozygous for the HFE 845A (C282Y) mutation and 25 (11.3%) were heterozygous for the same mutation, of whom 3 (1.3%) were compound heterozygotes also carrying the HFE 187G (H63D) mutation. 10695662

2000

dbSNP: rs1799945
rs1799945
0.070 GeneticVariation BEFREE One of the 220 patients (0.45%) with diabetes was homozygous for the HFE 845A (C282Y) mutation and 25 (11.3%) were heterozygous for the same mutation, of whom 3 (1.3%) were compound heterozygotes also carrying the HFE 187G (H63D) mutation. 10695662

2000

dbSNP: rs137852783
rs137852783
0.040 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000

dbSNP: rs1240512008
rs1240512008
0.010 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000

dbSNP: rs143517122
rs143517122
0.010 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000

dbSNP: rs754907741
rs754907741
0.010 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000

dbSNP: rs763010207
rs763010207
0.010 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000

dbSNP: rs779271027
rs779271027
0.010 GeneticVariation BEFREE Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%). 10720084

2000